PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
03-Feb-2022 Ermium Therapeutics Announces the Formation of a Scientific Advisory Board Businesswire
03-Feb-2022 Worldwide Clinical Trials and Ledger Run Partner to Optimize Clinical Research Business Operations Businesswire
03-Feb-2022 BioCardia Receives FDA Breakthrough Device Designation for CardiAMP Cell Therapy System for Heart Failure Businesswire
03-Feb-2022 Curie Therapeutics Appoints Kapil Dhingra, MBBS, to Board of Directors Businesswire
03-Feb-2022 ADCETRIS® Combination Significantly Improves Overall Survival in Newly Diagnosed Patients with Advanced Hodgkin Lymphoma Businesswire
03-Feb-2022 Charles River Laboratories Announces Wind Contract with Repsol for European Operations Businesswire
03-Feb-2022 Redwire Announces Preliminary Full Year 2021 Revenue and Backlog; Provides Update on Q3 2021 10-Q Filing Businesswire
03-Feb-2022 Marinus Pharmaceuticals Completes In Vivo M2 Metabolite Study and Provides European Regulatory Update Businesswire
03-Feb-2022 Surmodics Reports First Quarter Fiscal 2022 Results Businesswire
03-Feb-2022 JCR Pharmaceuticals Receives the WORLDSymposiumâ„¢ New Treatment Award for IZCARGO® (Pabinafusp Alfa) Businesswire
03-Feb-2022 KalVista Pharmaceuticals to Present at SVB Leerink Global Healthcare Conference Businesswire
03-Feb-2022 PENTAX Medical Europe launches premium solution PlasmaTYPHOON+ PENTAX Medical Europe
03-Feb-2022 Investigation Report on China's Pegylated Recombinant Human Granulocyte Colony Stimulating Factor (PEG-rhG-CSF) Market, 2021-2025 - ResearchAndMarkets.com Businesswire
03-Feb-2022 Global 3D Printed Medical Devices Market Report 2021: Data from 2020, Estimates for 2021, 2022 and 2024, CAGR Projections through 2026 - ResearchAndMarkets.com Businesswire
03-Feb-2022 Global Antifungal Agents Market Report 2021-2027 Featuring Major Players - Abbott Laboratories, Pfizer, and Bayer - ResearchAndMarkets.com Businesswire
03-Feb-2022 Regio Biosciences Enters into License Agreement with AstraZeneca for Phase 2a Asset in Peripheral Artery Disease (PAD) Businesswire
03-Feb-2022 Two Day Pharma Professionals Project Management Training Course, March 24th-25th, 2022 - ResearchAndMarkets.com Businesswire
03-Feb-2022 Abiomed Announces Record Revenue of $261 Million, up 13% Year Over Year Businesswire
03-Feb-2022 Uppsala University Hospital Selects Proscia to Deliver Full-Scale Digital Pathology Adoption Businesswire
03-Feb-2022 GRO Biosciences to Present at 2022 BIO CEO & Investor Conference Businesswire